ArticleEClinicalMedicine2025

Safety and clinical efficacy of Relmacabtagene autoleucel (relma-cel) for systemic lupus erythematosus: a phase 1 open-label clinical trial.

Jinhui Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.